Log in
Enquire now
‌

US Patent 9982018 Amatoxin derivatives

Patent 9982018 was granted and assigned to Heidelberg Pharma on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Heidelberg Pharma
Heidelberg Pharma
0
Current Assignee
Heidelberg Pharma
Heidelberg Pharma
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99820180
Patent Inventor Names
Christoph Müller0
Werner Simon0
Torsten Hechler0
Christian Lutz0
Jan Anderl0
Date of Patent
May 29, 2018
0
Patent Application Number
147699700
Date Filed
March 10, 2014
0
Patent Primary Examiner
‌
Peter J Reddig
0
Patent abstract

The invention relates to tumor therapy. In one aspect, the present invention relates to conjugates of an amatoxin and a target-binding moiety, e.g. an antibody, connected by certain linkages, which are useful in the treatment of cancer and other disorders and diseases. In a further aspect the invention relates to pharmaceutical compositions comprising such conjugates.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9982018 Amatoxin derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.